Denver, Colorado
Phase 1 cancer trials in Denver, CO
64 Phase 1 cancer studies are recruiting participants at sites in Denver as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Denver at a glance
- 64 studies are recruiting at a site in Denver.
- By phase: Phase 1 (34), Phase 1/2 (30).
- By sponsor: industry (62), university, hospital or other (2).
- By research area: Breast Cancer (18), Lung Cancer (17), Lymphoma (14), Prostate Cancer (6), Melanoma (5), Pancreatic Cancer (4).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Denver
Basic details from each study's public record (the 30 most recently updated of 64). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- Sarah Cannon Research Institute at HealthONE
- Registry record
- NCT07503808 · updated
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 19 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Study site
- SCRI at HealthOne
- Registry record
- NCT06586957 · updated
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Study site
- Sarah Cannon Research Institute at HealthONE
- Registry record
- NCT07029399 · updated
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Sarah Cannon Research Institute at HealthOne
- Registry record
- NCT06465069 · updated
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Cogent Biosciences, Inc.
- Study site
- Sarah Cannon Research Institute (SCRI) at HealthONE-Denver
- Registry record
- NCT07383506 · updated
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Nammi Therapeutics Inc
- Study site
- Sarah Cannon Research Institute - Denver DDU
- Registry record
- NCT06582017 · updated
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- BeOne Medicines
- Study site
- Sarah Cannon Research Institute (Scri) At Health One
- Registry record
- NCT06120283 · updated
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- ModeX Therapeutics, An OPKO Health Company
- Study site
- Sarah Cannon Research Institute
- Registry record
- NCT06239194 · updated
SMP-3124LP in Adults With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Sumitomo Pharma America, Inc.
- Study site
- Sarah Cannon Research Institute at HealthOne
- Registry record
- NCT06526819 · updated
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- Sarah Cannon Research Institute at HealthONE - Denver /ID# 258926
- Registry record
- NCT06084481 · updated
A Study of PHST001 in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pheast Therapeutics
- Study site
- Sarah Cannon Research Institute (SCRI) Oncology Partners - Denver Health One
- Registry record
- NCT06840886 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Denver, CO on ClinicalTrials.gov.
Lung cancer studies recruiting in Denver
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Bayer
- Study site
- Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's
- Registry record
- NCT06914128 · updated
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study sites
- Presbyterian/St Lukes Medical Center · Sarah Cannon Research Institute at HealthONE
- Registry record
- NCT07519655 · updated
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- Sarah Cannon Cancer Institute at HealthONE
- Registry record
- NCT06720987 · updated
DBC-664 in Adult Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Duboce Biopharmaceuticals, Inc.
- Study site
- Sarah Cannon Research Institute - Denver HealthONE
- Registry record
- NCT07705035 · updated
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Tango Therapeutics, Inc.
- Study site
- Sarah Cannon Research Institute Denver
- Registry record
- NCT06922591 · updated
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- Avenzo Therapeutics, Inc.
- Study site
- Avenzo Therapeutics Recruiting Site
- Registry record
- NCT07038343 · updated
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kura Oncology, Inc.
- Study site
- Sarah Cannon Research Institute at HealthONE
- Registry record
- NCT06026410 · updated
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study site
- Rocky Mountain Cancer Centers,LLP
- Registry record
- NCT07227298 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Denver, CO on ClinicalTrials.gov.
Prostate cancer studies recruiting in Denver
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Amgen
- Study site
- Rocky Mountain Cancer Centers
- Registry record
- NCT04221542 · updated
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Regeneron Pharmaceuticals
- Study site
- Sarah Cannon Research Institute (SCRI)
- Registry record
- NCT03972657 · updated
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Sarah Cannon Research Institute 1
- Registry record
- NCT06800313 · updated
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Sarah Cannon Research Institute
- Registry record
- NCT07206056 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Denver, CO on ClinicalTrials.gov.
Lymphoma studies recruiting in Denver
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study site
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
- Registry record
- NCT04726241 · updated
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Colorado Blood Cancer Institute ( Site 7000)
- Registry record
- NCT07519772 · updated
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Colorado Blood Cancer Institute
- Registry record
- NCT07101328 · updated
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Colorado Blood Cancer Institute
- Registry record
- NCT07226843 · updated
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- Phase 1/2
- Ages 13 to 90
- All sexes
- Sponsor
- Vironexis Biotherapeutics Inc.
- Study site
- Colorado Blood Cancer Institute
- Registry record
- NCT06533579 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Denver, CO on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Denver
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Artios Pharma Ltd
- Study site
- Sarah Cannon Research Institute at HealthONE
- Registry record
- NCT04657068 · updated
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study site
- SCRI at HCA Health One
- Registry record
- NCT07186842 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Denver, CO on ClinicalTrials.gov.
Ask about studies near Denver
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Colorado
All Colorado locations
126 studies recruiting across 10 cities.
Aurora
56 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections